Cutaneous T-Cell–Rich Lymphoid Infiltrates After SARS-CoV-2 Vaccination-Reference-Cited by-同舟云学术

Cutaneous T-Cell–Rich Lymphoid Infiltrates After SARS-CoV-2 Vaccination

Published:2022-09-01 Issue:9 Volume:158 Page:1073
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Hooper Madeline J.¹,Veon Francesca L.¹,LeWitt Tessa M.¹,Chung Christopher¹,Choi Jaehyuk¹,Zhou Xiaolong A.¹,Guitart Joan¹

Affiliation:

1. Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois

Abstract

This case series study describes cutaneous T-cell–rich lymphoid infiltrates characterized by papulonodules on the trunk and/or extremities in 6 patients after receiving the Pfizer/BioNTech COVID-19 mRNA vaccine.

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2794398/jamadermatology_hooper_2022_ld_220017_1662573757.22105.pdf

Reference6 articles.

1. Cutaneous complications of mRNA and AZD1222 COVID-19 vaccines: a worldwide review.;Kroumpouzos;Microorganisms,2022

2. Rare lymphomatoid reactions following SARS-CoV-2 vaccination.;LeWitt;JAAD Case Rep,2022

3. Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination.;Brumfiel;Leuk Lymphoma,2021

4. SARS-CoV-2 mRNA vaccine injection site pseudolymphoma.;Mintoff;J Eur Acad Dermatol Venereol,2022

5. COVID-19 vaccine frontrunners and their nanotechnology design.;Chung;ACS Nano,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Sentient Propagation-Reactive B Cell-Rich Lymphoid Proliferation;Annals of Cytology and Pathology;2024-07-13

2. Cutaneous Pseudolymphoma after COVID-19 Vaccine Injection;Indian Journal of Dermatology;2024-05

3. Rare COVID-19 vaccine side effects got lost in the shuffle. Primary cutaneous lymphomas following COVID-19 vaccination: a systematic review;Frontiers in Medicine;2024-04-10

4. Exploring cutaneous lymphoproliferative disorders in the wake of COVID‐19 vaccination;Skin Health and Disease;2024-03-25

5. Primary Cutaneous CD4 Small/Medium T-Cell Lymphoproliferative Disorder Following COVID-19 Vaccination—What Do We Know about Lymphoproliferative Disorders and Cutaneous Lymphomas after COVID-19 Vaccination? A Report of an Atypical Case and a Review of the Literature;Life;2024-03-14